首页> 外国专利> COMPOUND FOR THE SEQUESTRATION OF UNDESIRABLE ANTIBODIES IN A PATIENT

COMPOUND FOR THE SEQUESTRATION OF UNDESIRABLE ANTIBODIES IN A PATIENT

机译:用于患者中不希望的抗体的封存的化合物

摘要

The present invention provides a compound for the sequestration of undesirable antibodies (e.g. related to an autoimmune disease) in a patient. The compound comprises an inert biopolymer scaffold and at least a first peptide n-mer of the general formula P(-S-P)(n-1) and a second peptide n-mer of the general formula P(-S-P)(n-1); wherein, independently for each occurrence, P is a peptide with a sequence length of 2-13 amino acids and S is a non-peptide spacer, wherein, independently for each of the peptide n-mers, n is an integer of at least 1, wherein each of the peptide n-mers is bound to the biopolymer scaffold. Also provided are pharmaceutical compositions comprising the compound, as well as a method of sequestering one or more antibodies present in an individual and a method of inhibiting an immune reaction to a treatment with an active agent.
机译:本发明提供了一种用于在患者中封存不希望的抗体(例如与自身免疫疾病相关)的化合物。 该化合物包含惰性生物聚合物支架和通式P(-P)(N-1)的通式P(-SP)(N-1)的第一肽N-MER,以及通式P(-SP)的第二肽N-MER(N-1 ); 其中,对于每种发生,P是具有2-13个氨基酸序列长度的肽,并且S是非肽间隔物,其中,对于每个肽N-MERS,n是至少1的整数。 ,其中肽N-MERS中的每一个与生物聚合物支架结合。 还提供了包含该化合物的药物组合物,以及螯合在个体中存在的一种或多种抗体的方法和抑制用活性剂处理的免疫反应的方法。

著录项

  • 公开/公告号US2021369856A1

    专利类型

  • 公开/公告日2021-12-02

    原文格式PDF

  • 申请/专利权人 ABLEVIA BIOTECH GMBH;

    申请/专利号US202117393626

  • 发明设计人 OSKAR SMRZKA;BETTINA WANKO;

    申请日2021-08-04

  • 分类号A61K47/68;C07K5/04;A61K47/64;C07K7/06;

  • 国家 US

  • 入库时间 2022-08-24 22:35:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号